101 related articles for article (PubMed ID: 27525951)
21. Exploration of potential EGFR inhibitors: a combination of pharmacophore-based virtual screening, atom-based 3D-QSAR and molecular docking analysis.
Sudha A; Srinivasan P; Rameshthangam P
J Recept Signal Transduct Res; 2015 Apr; 35(2):137-48. PubMed ID: 25069678
[TBL] [Abstract][Full Text] [Related]
22. Structure-based pharmacophore mapping and virtual screening of natural products to identify polypharmacological inhibitor against c-MET/EGFR/VEGFR-2.
Varma DA; Singh M; Wakode S; Dinesh NE; Vinaik S; Asthana S; Tiwari M
J Biomol Struct Dyn; 2023 Apr; 41(7):2956-2970. PubMed ID: 35196966
[TBL] [Abstract][Full Text] [Related]
23. Binding mode of inhibitors and Cryptosporidium parvum IMP dehydrogenase: A combined ligand- and receptor-based study.
Li RJ; Wang YL; Wang QH; Huang WX; Wang J; Cheng MS
SAR QSAR Environ Res; 2015; 26(5):421-38. PubMed ID: 25978645
[TBL] [Abstract][Full Text] [Related]
24. The apoptosis inducing effect of Glycosmis pentaphylla (Retz.) Correa and its influence on gene expression in hepatocellular carcinoma cell line, Hep3 B.
Sreejith PS; Mascarenhas RR; Praseeja RJ; Asha VV
J Ethnopharmacol; 2012 Jan; 139(2):359-65. PubMed ID: 22138516
[TBL] [Abstract][Full Text] [Related]
25. The first pharmacophore model for potent G protein-coupled receptor 119 agonist.
Zhu X; Huang D; Lan X; Tang C; Zhu Y; Han J; Huang W; Qian H
Eur J Med Chem; 2011 Jul; 46(7):2901-7. PubMed ID: 21524831
[TBL] [Abstract][Full Text] [Related]
26. Target Fishing of Calactin, Calotropin and Calotoxin Using Reverse Pharmacophore Screening and Consensus Inverse Docking Approach.
Parthasarathy V; Menon AR; Devaranavadagi B
Curr Drug Discov Technol; 2021; 18(6):e130921188782. PubMed ID: 33292137
[TBL] [Abstract][Full Text] [Related]
27. Pharmacophore, 3D-QSAR, and Bayesian model analysis for ligands binding at the benzodiazepine site of GABAA receptors: the key roles of amino group and hydrophobic sites.
Yang Y; Zhang W; Cheng J; Tang Y; Peng Y; Li Z
Chem Biol Drug Des; 2013 May; 81(5):583-90. PubMed ID: 23279907
[TBL] [Abstract][Full Text] [Related]
28. An integrated virtual screening approach for VEGFR-2 inhibitors.
Zhang Y; Yang S; Jiao Y; Liu H; Yuan H; Lu S; Ran T; Yao S; Ke Z; Xu J; Xiong X; Chen Y; Lu T
J Chem Inf Model; 2013 Dec; 53(12):3163-77. PubMed ID: 24266594
[TBL] [Abstract][Full Text] [Related]
29. Computer-aided identification of novel protein targets of bisphenol A.
Montes-Grajales D; Olivero-Verbel J
Toxicol Lett; 2013 Oct; 222(3):312-20. PubMed ID: 23973438
[TBL] [Abstract][Full Text] [Related]
30. Discovery of potent inhibitor for matrix metalloproteinase-9 by pharmacophore based modeling and dynamics simulation studies.
Kalva S; Azhagiya Singam ER; Rajapandian V; Saleena LM; Subramanian V
J Mol Graph Model; 2014 Apr; 49():25-37. PubMed ID: 24473069
[TBL] [Abstract][Full Text] [Related]
31. Assessing an ensemble docking-based virtual screening strategy for kinase targets by considering protein flexibility.
Tian S; Sun H; Pan P; Li D; Zhen X; Li Y; Hou T
J Chem Inf Model; 2014 Oct; 54(10):2664-79. PubMed ID: 25233367
[TBL] [Abstract][Full Text] [Related]
32. Sunitinib: from charge-density studies to interaction with proteins.
Malińska M; Jarzembska KN; Goral AM; Kutner A; Woźniak K; Dominiak PM
Acta Crystallogr D Biol Crystallogr; 2014 May; 70(Pt 5):1257-70. PubMed ID: 24816095
[TBL] [Abstract][Full Text] [Related]
33. Designing of potential inhibitors against Staphylococcus aureus sortase A: Combined analogue and structure based approach with in vitro validation.
Raj KK; Ganesh Kumar V; Leela Madhuri C; Mathi P; Durga Lakshmi R; Ravi M; Sri Ramudu B; Venkata Rao SV; Ramachandran D
J Mol Graph Model; 2015 Jul; 60():89-97. PubMed ID: 26119984
[TBL] [Abstract][Full Text] [Related]
34. Discovery and optimization of triazine derivatives as ROCK1 inhibitors: molecular docking, molecular dynamics simulations and free energy calculations.
Shen M; Zhou S; Li Y; Pan P; Zhang L; Hou T
Mol Biosyst; 2013 Mar; 9(3):361-74. PubMed ID: 23340525
[TBL] [Abstract][Full Text] [Related]
35. Molecular simulation studies on the binding selectivity of 2-anilino-4-(thiazol-5-yl)-pyrimidines in complexes with CDK2 and CDK7.
Chohan TA; Qian HY; Pan YL; Chen JZ
Mol Biosyst; 2016 Jan; 12(1):145-61. PubMed ID: 26565382
[TBL] [Abstract][Full Text] [Related]
36. Protein-ligand-based pharmacophores: generation and utility assessment in computational ligand profiling.
Meslamani J; Li J; Sutter J; Stevens A; Bertrand HO; Rognan D
J Chem Inf Model; 2012 Apr; 52(4):943-55. PubMed ID: 22480372
[TBL] [Abstract][Full Text] [Related]
37. Prediction of binding modes and affinities of 4-substituted-2,3,5,6-tetrafluorobenzenesulfonamide inhibitors to the carbonic anhydrase receptor by docking and ONIOM calculations.
Samanta PN; Das KK
J Mol Graph Model; 2016 Jan; 63():38-48. PubMed ID: 26619075
[TBL] [Abstract][Full Text] [Related]
38. GRID-based three-dimensional pharmacophores I: FLAPpharm, a novel approach for pharmacophore elucidation.
Cross S; Baroni M; Goracci L; Cruciani G
J Chem Inf Model; 2012 Oct; 52(10):2587-98. PubMed ID: 22970894
[TBL] [Abstract][Full Text] [Related]
39. Identification of a potential anticancer target of danshensu by inverse docking.
Chen SJ; Ren JL
Asian Pac J Cancer Prev; 2014; 15(1):111-6. PubMed ID: 24528010
[TBL] [Abstract][Full Text] [Related]
40. Identification of potential transmembrane protease serine 4 inhibitors as anti-cancer agents by integrated computational approach.
Ilamathi M; Hemanth R; Nishanth S; Sivaramakrishnan V
J Theor Biol; 2016 Jan; 389():253-62. PubMed ID: 26590327
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
